244 results on '"De Baets, M."'
Search Results
2. Titin antibodies in “seronegative” myasthenia gravis — A new role for an old antigen
3. MuSK autoantibodies in myasthenia gravis detected by cell based assay — A multinational study
4. A mouse model of the slow channel myasthenic syndrome: Neuromuscular physiology and effects of ephedrine treatment
5. The role of interleukin-1 in seizures and epilepsy: A critical review
6. Pain and autonomic dysfunction in patients with sarcoidosis and small fibre neuropathy
7. Cognitive fMRI and soluble telencephalin assessment in patients with localization-related epilepsy
8. The features of myasthenia gravis with autoantibodies to MuSK
9. Small fiber neuropathy: a common and important clinical disorder
10. Immunoregulation in Experimental Autoimmune Myasthenia Gravis—about T Cells, Antibodies, and Endplates
11. Abstracts
12. Acquired neuromyotonia: superiority of plasma exchange over high-dose intravenous human immunoglobulin
13. Association of the Fcγ receptor IIA-R/R131 genotype with myasthenia gravis in Dutch patients
14. The role of antibodies in myasthenia gravis
15. Differential Susceptibility of Young and Old Rat Neuromuscular Junctions to Antibody-mediated AChR Degradation in Experimental Autoimmune Myasthenia Gravis
16. Guillain-Barre syndrome in mother and newborn child
17. Age- and sex-related resistance to chronic experimental autoimmune myasthenia gravis (EAMG) in Brown Norway rats
18. Folgen des Absetzens von Natalizumab auf die Krankheitsaktivität und das Immunsystem bei der Multiplen Sklerose
19. EP14.02-06 Mixed Feelings about Mixed Thymomas.
20. Small fibre neuropathy in sarcoidosis
21. Clinical and scientific aspects of acetylcholine receptor myasthenia gravis
22. Inflammation, Depressive Symptomatology, and Coronary Artery Disease
23. Effects of the rate of acetylcholine receptor synthesis on the severity of experimental autoimmune myasthenia gravis
24. Specificities of autoantibodies in autoimmune receptor diseases
25. Myasthenia gravis
26. Erratum: gene-environment interaction research and transgenic mouse models of Alzheimer's disease
27. Foreword
28. P10.12 Single fibre electromyography in an experimental non-human primate model of acute myasthenia gravis: normal jitter values in rhesus monkeys
29. Gene-Environment Interaction Research and Transgenic Mouse Models of Alzheimer's Disease
30. Main Immunogenic Region Structure Promotes Binding of Conformation-Dependent Myasthenia Gravis Autoantibodies, Nicotinic Acetylcholine Receptor Conformation Maturation, and Agonist Sensitivity
31. Intraepidermal nerve fiber density and its application in sarcoidosis
32. Immunologic, clinical, and radiologic status 14 months after cessation of natalizumab therapy
33. M.I.5 Auto antibody mediated effector mechanisms in myasthenia gravis and its animal model: About antibodies and anchor proteins
34. Folgen des Absetzens von Natalizumab auf die Krankheitsaktivität und das Immunsystem bei der Multiplen Sklerose
35. Strong association of MuSK antibody-positive myasthenia gravis and HLA-DR14-DQ5
36. Decreased number of acetylcholine receptors is the mechanism that alters the time course of muscle relaxants in myasthenia gravis
37. Modelling of rocuronium and pancuronium in the anterograde perfused peroneal nerve anterior tibialis muscle model of the ‘myasthenic rat’ vs. control
38. Anti-Hu antibody titre and brain metastases before and after treatment for small cell lung cancer
39. Polarization toward the T-helper(TH)1 type immune response is not required for rat experimental autoimmune myasthenia gravis
40. Fab fragments isolated from thymus of myasthenia gravis patients reflect predominant specificities in serum and block the action of serum antibodies
41. Differential susceptibility of young and aged rat muscle to antibody-mediated AChR degradation in experimental autoimmune myasthenia gravis (EAMG)
42. Human anti-nicotinic acetylcholine receptor recombinant Fab fragments isolated from thymus-derived phage display libraries from myasthenia gravis patients reflect predominant specificities in serum and block the action of pathogenic serum antibodies.
43. Sequence analysis of anti-AChR antibodies in experimental autoimmune myasthenia gravis.
44. Molecular analysis of anti-acetylcholine receptor antibodies in experimental autoimmune myasthenia gravis (EAMG)
45. Hu antigens and anti‐Hu antibodies in a patient with myxoid chondrosarcoma
46. SFEMG studies in experimental autoimmune myasthenia gravis. Differences between young and aged rats
47. Characterization of anti-acetylcholine receptor (AChR) antibodies from mice differing in susceptibility for experimental autoimmune myasthenia gravis (EAMG)
48. Age-related resistance to experimental autoimmune myasthenia gravis in rats.
49. Immunoglobuline VH gene utilization of auto-antibodies to the acetylcholine receptor in experimental autoimmune myasthenia gravis
50. Role of acetylcholine receptor antibody complexes in experimental autoimmune myasthenia gravis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.